Biosafety Laboratory Facility (BSL)-3


Following the COVID-19 epidemics, we have secured funding from the Brazilian Scientific Research Council (CNPq) to develop a novel BCG-based SARS-Cov-2 vaccine. We are happy to inform the scientific community that the construction of our BSL-3 facility has been initiated and is planned to begin operation in September, 2022. 

We expect procedures, operation, schedules will be available to the Scientific Community by August, 2022.

 The new BSL-3 Facility


Prof. André Báfica    Prof. Daniel Mansur